Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas.
Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas.
复制标题
(13)C NMR 检测异柠檬酸脱氢酶突变神经胶质瘤组织提取物中 2-羟基戊二酸的条件。
DOI:
10.1016/j.ab.2015.04.017
复制
发表时间:
2015
影响因子:
2.9
通讯作者:
Kovacs,Zoltan
中科院分区:
文献类型:
--
作者:
Pichumani,Kumar;Mashimo,Tomoyuki;Baek,Hyeon-Man;Ratnakar,James;Mickey,Bruce;DeBerardinis,RalphJ;Maher,ElizabethA;Bachoo,RobertM;Malloy,CraigR;Kovacs,Zoltan
13C NMR (nuclear magnetic resonance) spectroscopy of extracts from patient tumor samples provides rich information about metabolism. However, in isocitrate dehydrogenase (IDH)-mutant gliomas,13C labeling is obscured in oncometabolite 2-hydroxyglutaric acid (2HG) by glutamate and glutamine, prompting development of a simple method to resolve the metabolites. J-coupled multiplets in 2HG were similar to glutamate and glutamine and could be clearly resolved at pH 6. A cryogenically cooled13C probe, but not J-resolved heteronuclear single quantum coherence spectroscopy, significantly improved detection of 2HG. These methods enable the monitoring of13C–13C spin–spin couplings in 2HG expressing IDH-mutant gliomas.